Pauline Maisonnasse

Nantes, 44300, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Algae extract supplementation boosts humoral immunity induced by attenuated PRRSV-1 vaccination.

Algae extract supplementation boosts humoral immunity induced by attenuated PRRSV-1 vaccination.

Journal: BMC veterinary research
Published: June 05, 2025

Differential impact of porcine reproductive and respiratory virus and swine Influenza A virus infections on respiratory Lymph Nodes B cells and macrophages.

Differential impact of porcine reproductive and respiratory virus and swine Influenza A virus infections on respiratory Lymph Nodes B cells and macrophages.

Journal: Molecular immunology
Published: June 02, 2025

Induction of HIV-1-specific antibody-mediated effector functions by native-like envelope trimers in humans.

Induction of HIV-1-specific antibody-mediated effector functions by native-like envelope trimers in humans.

Journal: PLoS pathogens
Published: January 19, 2025

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.

Journal: Frontiers in immunology
Published: July 31, 2023

Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.

Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.

Journal: PLoS computational biology
Published: November 08, 2022

Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates.

Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates.

Journal: NPJ vaccines
Published: June 08, 2022

Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development.

Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development.

Journal: Frontiers in microbiology
Published: April 29, 2022

Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.

Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.

Journal: Nature communications
Published: March 17, 2022

Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques.

Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 07, 2022

A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model.

A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model.

Journal: Frontiers in immunology
Published: January 14, 2022

Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates.

Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates.

Journal: iScience
Published: November 17, 2021

Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection.

Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection.

Journal: Gastro hep advances
Published: November 15, 2021
Showing 1-12 of 42

Last Updated: 09/26/2026